Interesting. I’ve been taking a compound tablet that was labeled as Exforg for the last five years. The information on this drug is as follows:
Exforge is the brand name of an oral blood pressure lowering medication which combines two medications in a film-coated tablet. It contains amlodipine, a dihydropyridine-type calcium channel blocker, and valsartan, an angiotensin II receptor antagonist (ARB or A2RA). The patent is held by Novartis Pharmaceuticals. Novartis markets valsartan as Diovan. The patent expired in September 2012.[1] Pfizer’s patent on amlodipine expired in 2007. Until then, it was marketed as Norvasc.
Now prior to Exforg, I was taking the two component medications. At first Exforg was expensive but now it is sold as a reasonably priced generic. It has been quite effective and a part of a treatment by my nephrologist that has see my kidney function go from a low of 13% to its current 38% to 45%. Needless to say I’m well satisfied with my physician.
Yes, but before the combination went generic, you probably could have gotten as good a result taking two tablets separately. That’s the kind of abuse that needs to be tracked down and dealt with.